A comprehensive review of patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease

被引：0

作者：

Sapmaz, Aybuke ^{[1
]}

Paik, Annette ^{[2
]}

Henry, Linda ^{[1
,2
,3
]}

Younossi, Zobair M. ^{[1
,2
,3
]}

机构：

[1] Global NASH Council, Ctr Outcomes Res Liver Dis, 2411 1 St, Washington, DC 20023 USA

[2] Inova Hlth Syst, Beatty Liver & Obes Res Program, Falls Church, VA 22042 USA

[3] Ctr Outcomes Res Liver Dis, Washington, DC 20023 USA

来源：

METABOLISM AND TARGET ORGAN DAMAGE | 2024年 / 4卷 / 04期

关键词：

NAFLD; MAFLD; patient-reported outcome (PRO); quality of life; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CLINICAL-TRIALS; HEPATITIS-C; FATIGUE; IMPACT; QUESTIONNAIRE; VALIDATION; PERFORMANCE; INSTRUMENT;

D O I：

10.20517/mtod.2024.70

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

of other patient-centric outcomes and provides insights for the healthcare community to develop interventions that could improve both clinical and humanistic outcomes for individuals living with MASLD/MASH.

引用

页数：11

共 50 条

[1] Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
Barbera, Aurora
White, Trenton M.
Arora, Anish K.
Henry, Linda
Lazarus, Jeffrey V.
Younossi, Zobair M.
SEMINARS IN LIVER DISEASE, 2024,
[2] Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease
Hashida, Ryuki
Kawaguchi, Takumi
Nakano, Dan
Tsutsumi, Tsubasa
Kawaguchi, Machiko
Takahashi, Hirokazu
Tajima, Hiroshi
Matsuse, Hiroo
Golabi, Pegah
Gerber, Lynn H.
Younossi, Zobair M.
Hiraoka, Koji
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (02) : 190 - 197
[3] A prospective assessment of disease progression impact on patient-reported outcomes in metabolic dysfunction-associated steatotic liver disease
O'Connor, Ian P.
Neuschwander-Tetri, Brent A.
Newsome, Philip N.
Mospan, Andrea
Morris, Heather
Schoen, Cheryl
Barritt, A. Sidney
Sanyal, Arun J.
JOURNAL OF HEPATOLOGY, 2024, 80 : S472 - S473
[4] A PROSPECTIVE ASSESSMENT OF THE IMPACT OF DECOMPENSATION OF CIRRHOSIS ON PATIENT-REPORTED OUTCOMES IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
O'Connor, Ian
Mospan, Andrea
Schoen, Cheryl
Barritt, Alfred
Sanyal, Arun
HEPATOLOGY, 2024, 80 : S843 - S844
[5] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Zheng, Haixiang
Sechi, Leonardo Antonio
Navarese, Eliano Pio
Casu, Gavino
Vidili, Gianpaolo
CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
[6] Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
Eskridge, Wayne
Cryer, Donna R.
Schattenberg, Joern M.
Gastaldelli, Amalia
Malhi, Harmeet
Allen, Alina M.
Noureddin, Mazen
Sanyal, Arun J.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
[7] Metabolic Dysfunction-Associated Steatotic Liver Disease
Ali, Sajjadh M. J.
Lai, Michelle
ANNALS OF INTERNAL MEDICINE, 2025, 178 (01) : ITC1 - ITC17
[8] Endocrinologist's crucial role in metabolic dysfunction-associated steatotic liver disease: a comprehensive review
Reytor-Gonzalez, Claudia
Annunziata, Giuseppe
Campuzano-Donoso, Martin
Morales-Lopez, Tania
Basantes-Tituana, Carmen
Fasci-Spurio, Federica
Verde, Ludovica
Muscogiuri, Giovanna
Barrea, Luigi
Frias-Toral, Evelyn
Simancas-Racines, Daniel
MINERVA ENDOCRINOLOGY, 2025,
[9] Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
Abenavoli, Ludovico
Statsenko, Michael
Scarlata, Giuseppe Guido Maria
Morano, Domenico
Myazin, Roman
Emelyanov, Dmitriy
LIVERS, 2024, 4 (04): : 495 - 506
[10] Metabolic dysfunction-associated steatotic liver disease and the heart
Driessen, Stan
Francque, Sven M.
Anker, Stefan D.
Cabezas, Manuel Castro
Grobbee, Diederick E.
Tushuizen, Maarten E.
Holleboom, Adriaan G.
HEPATOLOGY, 2023,

← 1 2 3 4 5 →